We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.23B
AUM Growth
+$208M
Cap. Flow
+$22.5M
Cap. Flow %
0.53%
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181
Avg Time Held Equity + Options
4.4 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.6 quarters
Avg Time Held Equity only
4.5 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.6 quarters

Top Buys

Rank Stock Value
1
ITCI icon
Intra-Cellular Therapies Inc.
ITCI
+$383M
2
DFS icon
Discover Financial Services
DFS
+$224M
3
BECN icon
Beacon Roofing Supply, Inc.
BECN
+$183M
4
WBA icon
Walgreens Boots Alliance
WBA
+$110M
5
JWN icon
Nordstrom
JWN
+$95.8M

Top Sells

Rank Stock Value
1
HCP icon
HashiCorp, Inc. Class A Common Stock
HCP
+$235M
2
SMAR icon
Smartsheet Inc.
SMAR
+$216M
3
EDR icon
Endeavor Group Holdings, Inc.
EDR
+$144M
4
SUM icon
Summit Materials, Inc. Class A Common Stock
SUM
+$103M
5
ALTR icon
Altair Engineering Inc
ALTR
+$97.9M

Sector Composition

Rank Sector Weight
1 Energy 17.21%
2 Healthcare 16.93%
3 Financials 12.93%
4 Industrials 12.5%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
EVLV icon
151
Evolv Technologies
EVLV
$821M
$1.34M 0.03%
430,223
– –
2021 Q3
14 quarters
IMCR icon
152
Immunocore
IMCR
$1.51B
$1.34M 0.03%
45,196
-78
-0.2% -$2.34K
2022 Q1
12 quarters
DG icon
153
Dollar General
DG
$28.1B
$1.32M 0.03%
+15,000
New +$1.14M
2025 Q1
0 quarters
BPMC icon
154
DELISTED
Blueprint Medicines
BPMC
$1.32M 0.03%
14,865
-5,268
-26% -$514K
2022 Q4
9 quarters
INSP icon
155
Inspire Medical Systems
INSP
$1.99B
$1.27M 0.03%
+8,000
New +$1.45M
2025 Q1
0 quarters
BCYC icon
156
Bicycle Therapeutics
BCYC
$272M
$1.26M 0.03%
148,722
+68,486
+85% +$807K
2022 Q1
12 quarters
TMCI icon
157
Treace Medical Concepts
TMCI
$257M
$1.24M 0.03%
147,695
-126,505
-46% -$1.14M
2022 Q1
12 quarters
XRX icon
158
PUT
Xerox
XRX
$361M
$1.22M 0.03%
278,300
– –
2021 Q2
15 quarters
QURE icon
159
uniQure
QURE
$1.57B
$1.22M 0.03%
114,889
-77,334
-40% -$1.08M
2022 Q4
9 quarters
SLNO icon
160
DELISTED
Soleno Therapeutics
SLNO
$1.22M 0.03%
17,022
+9,045
+113% +$440K
2024 Q2
3 quarters
IR icon
161
Ingersoll Rand
IR
$30.6B
$1.2M 0.03%
+15,000
New +$1.31M
2025 Q1
0 quarters
PTCT icon
162
PTC Therapeutics
PTCT
$5.4B
$1.19M 0.03%
23,353
-23,541
-50% -$1.17M
2022 Q4
9 quarters
KROS icon
163
Keros Therapeutics
KROS
$237M
$1.18M 0.03%
115,518
+64,621
+127% +$750K
2022 Q1
12 quarters
SDGR icon
164
Schrodinger
SDGR
$2.04B
$1.17M 0.03%
59,043
+12,129
+26% +$273K
2022 Q1
12 quarters
MLYS icon
165
Mineralys Therapeutics
MLYS
$2.07B
$1.16M 0.03%
73,348
+45,280
+161% +$521K
2023 Q4
5 quarters
DADA
166
DELISTED
Dada Nexus
DADA
$1.15M 0.03%
+618,986
New +$1.07M
2025 Q1
0 quarters
IDYA icon
167
IDEAYA Biosciences
IDYA
$3.48B
$1.14M 0.03%
69,474
-3,242
-4% -$69.1K
2022 Q3
10 quarters
ALCY icon
168
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
$1.13M 0.03%
100,248
– –
2024 Q1
4 quarters
DLTR icon
169
Dollar Tree
DLTR
$22.3B
$1.12M 0.03%
+14,900
New +$1.07M
2025 Q1
0 quarters
HYAC icon
170
DELISTED
Haymaker Acquisition Corp 4
HYAC
$1.1M 0.03%
100,248
– –
2023 Q3
6 quarters
VRNA
171
DELISTED
Verona Pharma
VRNA
$1.09M 0.03%
+17,150
New +$1.03M
2025 Q1
0 quarters
TPR icon
172
Tapestry
TPR
$23.2B
$1.06M 0.03%
+15,000
New +$1.14M
2025 Q1
0 quarters
NUVB icon
173
Nuvation Bio
NUVB
$1.76B
$1.04M 0.02%
+592,119
New +$1.35M
2025 Q1
0 quarters
GAP icon
174
The Gap Inc
GAP
$8.16B
$1.03M 0.02%
+50,000
New +$1.12M
2025 Q1
0 quarters
MRUS icon
175
DELISTED
Merus
MRUS
$1.02M 0.02%
24,232
+9,692
+67% +$423K
2022 Q1
12 quarters
5 6
7
8 9

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2025 Portfolio in Review

As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

UBS O'Connor's Q1 2025 filing shows 83 new, 81 increased, 97 reduced and 181 closed positions. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $235M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
  • UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
  • UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
  • UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
  • UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
  • UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
  • UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.